Given the increasing prevalence of diabetes and obesity worldwide, the deleterious effects
of non-alcoholic fatty liver disease (NAFLD) are becoming a growing challenge for public …

Non-alcoholic fatty liver disease (NAFLD) is one of the most frequent causes of chronic liver
disease in the Western world, probably due to the growing prevalence of obesity, metabolic …

Cigarette smoking is a preventable risk factor for premature morbidity and mortality. A history
of smoking is observed in approximately 40% of patients with liver disease, while a growing …

Nonalcoholic fatty liver disease (NAFLD) is now recognized as the most common cause of
chronic liver disease worldwide. Its prevalence has increased to more than 30% of adults in …

Given that little is known about the prevalence of, and factors associated with, liver fibrosis in
the general population, we aimed to investigate this in a large, well‐characterized cohort by …

Experimental evidence has shown that per-and polyfluoroalkyl substances (PFAS)
alternatives and mixtures may exert hepatotoxic effects in animals. However …

The risk factors for nonalcoholic fatty liver disease (NAFLD) have not been clearly identified.
We conducted a Mendelian randomization (MR) study to explore this. Independent genetic …

Background While tobacco and alcohol are established risk factors for hepatocellular
carcinoma (HCC), the most common type of primary liver cancer, it is unknown whether they …

Chronic obstructive pulmonary disease (COPD) is a major incurable global health burden
and is currently the 4th largest cause of death in the world. Importantly, much of the disease …

Atherosclerosis-prone apolipoprotein E-deficient (Apoe−/−) mice display poor lipoprotein
clearance with subsequent accumulation of cholesterol ester-enriched particles in the blood …